Canada markets open in 8 hours 52 minutes

Ensysce Biosciences, Inc. (ENSC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.5920+0.0170 (+2.96%)
At close: 04:00PM EDT
0.6000 +0.01 (+1.35%)
After hours: 07:37PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.49M
Enterprise Value 1.33M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.20
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.50

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 3-74.59%
S&P500 52-Week Change 323.33%
52 Week High 32.6400
52 Week Low 30.5120
50-Day Moving Average 30.6524
200-Day Moving Average 31.0757

Share Statistics

Avg Vol (3 month) 3140.53k
Avg Vol (10 day) 3185.83k
Shares Outstanding 57.59M
Implied Shares Outstanding 67.59M
Float 87.15M
% Held by Insiders 15.55%
% Held by Institutions 12.31%
Shares Short (Apr 30, 2024) 49.64k
Short Ratio (Apr 30, 2024) 40.1
Short % of Float (Apr 30, 2024) 40.13%
Short % of Shares Outstanding (Apr 30, 2024) 40.13%
Shares Short (prior month Mar 28, 2024) 417.48k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Mar 31, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-612.72%

Management Effectiveness

Return on Assets (ttm)-155.91%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.23M
Revenue Per Share (ttm)0.99
Quarterly Revenue Growth (yoy)-64.10%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-10.63M
Diluted EPS (ttm)-3.1600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.12M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)854.7k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.69
Book Value Per Share (mrq)-0.10

Cash Flow Statement

Operating Cash Flow (ttm)-10.78M
Levered Free Cash Flow (ttm)-7.42M